Task order - delivery order for DRI opiates IA kit
Ended Awarded Last action
- Contract number
- W91YTZ24F0103
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $8,135
Award facts
- Contract value 100% obligated
- $8,134.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Meade, MD 20755, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a delivery order valued at $8,134.80 to Microgenics Corporation for DRI Opiates IA Kit supplies, with a completion date of May 30, 2024. Microgenics Corporation, operating through its Clinical Diagnostics Division, is a manufacturer of clinical diagnostic products and immunoassay reagent test kits specializing in substance detection and toxicology screening. This delivery order was issued without a set-aside designation, reflecting the contractor's established competitive position in the federal marketplace. The place of performance is Fort Meade, Maryland.
This award supports the Department of Defense Drug Demand Reduction Program and substance abuse testing operations across military healthcare systems. Microgenics holds multiple single-award indefinite delivery contracts with the Defense Health Agency and related military agencies for various drug detection reagent kits, including specialized products for detecting opiates, benzodiazepines, amphetamines, and other controlled substances. The current delivery order for opiate detection kits aligns with the contractor's core business providing critical diagnostic reagents to support military and veteran healthcare substance abuse testing and treatment initiatives.
Quick answers
Who was awarded contract W91YTZ24F0103?
W91YTZ24F0103 was awarded to Microgenics Corporation by Medical Command (Department of the Army) on April 30, 2024.
How much is contract W91YTZ24F0103 worth?
The government has obligated $8,135 on W91YTZ24F0103.
Which agency awarded contract W91YTZ24F0103?
Medical Command (Department of the Army) awarded W91YTZ24F0103, with funding from Defense Health Agency (Department of Defense).
Is contract W91YTZ24F0103 an order under another contract?
Yes. W91YTZ24F0103 is a delivery order under N6264523D5006, an indefinite delivery contract.
Was contract W91YTZ24F0103 competed?
The extent of competition for W91YTZ24F0103 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award